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Abstract Over the last decade, improvement of CO2
lasers with the microspot and ultrapulse technologies
has broadened the indications for endoscopic CO2-laser
resection of benign laryngotracheal stenosis (LTS). This
article reviews 100 patients treated solely by endoscopic
means for a LTS. There were 47 grade III, 41 grade II
and 12 grade I stenoses according to the Myer-Cotton
classiﬁcation. The postoperative results show that the
improvement to a nearly normal (>80% luminal size)
airway declines from 92% (11/12 patients) for grade I to
46% (19/41 patients) for grade II and 13% (6/47 pa-
tients) for grade III stenoses. When compared to open
surgery for more severe grades of stenosis (31 grade IV,
66 grade III and 3 grade II stenoses), the results of the
endoscopy group is much less favorable: 36% of patients
in the endoscopy group versus 76% of patients in the
open surgery group were rehabilitated to a normal res-
piration without exertional dyspnea and 38% versus 5%
patients remained tracheotomy dependent. However, if
strict selection and therapeutic criteria are respected, a
signiﬁcant number of grade I and II stenoses, and to
a lesser degree of grade III stenoses, can be improved to
a nearly normal airway by endoscopic means only. The
endoscopic treatment is potentially less invasive and
risky and only needs a short hospital stay. To try this as
a ﬁrst treatment modality in a selected group of patients
is worthwhile, provided that this endoscopic treatment is
not repeated a second time, if the stenosis recurs to its
initial grade after a primary CO2-laser treatment. Some
guidelines for safe endoscopic treatment modalities with
of the CO2 laser, dilatation and/or stenting are pro-
posed.
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Introduction
The management of laryngotracheal stenosis (LTS) is a
challenging problem with no ﬁxed treatment algorithm
among the multiple options that are available to the
surgeon. The latter includes endoscopic treatments (CO2
laser, dilatation and/or stenting) [2, 7, 9, 10, 13, 14, 20,
22, 24, 25, 31, 35, 37, 38, 44, 45, 48] and open surgery
with enlargement procedures or resections, both with or
without stenting [1, 3, 4, 5, 6, 15, 16, 17, 18, 21, 26, 27,
28, 32, 36, 39, 42]. Each case is unique and has to be
judged according to the patient’s characteristics, the site
and severity of the stenosis and the function of the vocal
cords [26]. This renders the comparison of success rates
with diﬀerent treatment modalities diﬃcult. The ﬁnal
result depends not only on the severity of the initial
condition, but also greatly on the quality of the indica-
tion for the appropriate type of surgery. The preopera-
tive assessment is thus essential; it has been published in
detail elsewhere [26]. Notwithstanding, the ﬁnal outcome
can be judged on the restoration of an adequate airway
and on the preservation of a satisfactory voice. Needless
to say that selecting the right patient for the right type of
treatment is the key issue, although this may turn out to
be a very diﬃcult task, especially in multilevel stenoses
associated with glottal scarring or extensive tracheal
damage.
Several authors have published guidelines for the
management of LTS by open surgery [3, 4, 6, 15, 17, 27,
39] and by endoscopy [7, 10, 37, 45, 46]. Unfortunately,
some endoscopists tend to set up their own criteria based
on their level of expertise in their own discipline. This
leads to some unacceptable primary treatments with an
inappropriate type of laser (Nd-YAG used at a low
power-density in a non-contact mode, for example)
and long-term stenting, where a simple resection and
anastomosis would have straightforwardly solved the
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problem [16, 28, 39]. It must be clearly stated here that
an endoscopic treatment can seldom restore an ana-
tomically normal subglottis or trachea [44, 45]. How-
ever, the improvements of CO2 lasers with the microspot
and superpulse/ultrapulse technologies have recently




From 1991 to 2003, 115 patients with a benign LTS were
treated solely by endoscopic means at the University
Hospital CHUV, Lausanne, Switzerland. There were 51
males and 64 females with a mean age of 22 years
(range: 6 months to 73 years). Sixty-three (55%) were in
the pediatric age group. Preoperatively, 39 patients were
tracheototomy dependent, 46 had some dyspnea at rest
and 30 only some exertional dyspnea.
Almost half (52/115 45%) of the patients had al-
ready undergone one or several (1 to 50) previous
endoscopic treatments or open surgeries elsewhere. In
these cases, a further CO2 laser resection with or without
additional dilatation was only proposed when the aspect
of the stenosis showed as a residual web-like synechia
[46], a prolapse of one arytenoid [43] or a bilateral vocal
cord immobility [11, 41].
Stenosis
The stenosis was congenital in 8 patients, acquired after
intubation or external trauma in 98 patients and of
mixed etiology (congenital and acquired) in 9 patients.
According to the Myer-Cotton classiﬁcation (Table 1),
there were 47 (41%) patients with grade III stenoses, of
which 39 were tracheostomized and 8 had a severe
dyspnea at rest. In the group of 50 (44%) grade II
stenoses, 36 patients had a severe grade II (70%
airway obstruction) with slight dyspnea at rest and 14 a
mild grade II stenosis with exertional dyspnea only.
Finally, the 18 (15%) patients with only grade I ste-
nosis were essentially adults complaining of slight
dyspnea during sport activities. For combined stenoses,
the size of the most severe stenosis was taken into
consideration for the preoperative and postoperative
grading.
It must be clearly stated here that the above-men-
tioned indications diverge from the general recommen-
dations for the use of the CO2 laser in benign LTS [46],
but in this series, grade II and grade III stenoses always
presented as thin diaphragms.
Except for 7 (6%) solely supraglottic stenoses, the
other sites were almost equally distributed with 26
(23%) glottic, 26 (23%) subglottic, 29 (25%) tracheal
and 27 (23%) combined glotto-subglottic stenoses.
Treatment modality
The CO2 laser (Coherent Ultrapulse Encore) was always
used in the ultrapulse mode with a ﬂuence of 150 mJ/cm2
at a frequency of 10 Hz to avoid any charring and heat
diﬀusion into the surrounding tissues [33]. Dilatation
was performed with tapered Savary-Gilliard dilators
(Wilson-Cook Medical) after radial laser incisions [45],
and when necessary stenting was achieved with our own
laryngotracheal mold (Easy LT-Mold) [29].
When mitomycin-C was additionally used after the
endoscopic treatment, it was topically applied over the
raw surface of the laser wound at a dose of 2 mg/ml for
2 min [30].
Early in our experience, we also treated some tracheal
stenoses with the Nd-YAG laser in a contact mode using
a sapphire tip or with the KTP-laser. Currently, we only
use a rigid Storz bronchoscope with a CO2 laser coupler
(Storz 10316 LC).
The type of treatment applied is summarized in
Table 2. It must be noted that treatment modalities were
often combined to give the best possible result. Fifty-ﬁve
(48%) patients underwent a single and 54 (47%) patients
less than three endoscopic treatment sessions. In six
patients, the improvement at each session inclined us to
perform subsequent endoscopic treatments (maximum
5) to optimize the ﬁnal result. In 13 patients, open sur-
gery was eventually proposed to achieve a satisfactory
result.
In 15 cases, a temporary stenting with an Easy LT-
Mold [29] was deemed necessary for the treatment of a
posterior glottic stenosis (PGS). All these patients were
tracheotomy-dependent. Five other patients without
tracheotomy were kept intubated with a soft blue-line
Portex tube (Ru¨sch, Germany) for a mean duration of
1 week. The last ﬁve patients had a severe anterior syne-
chia of the vocal cords that was treated by a CO2 laser
division and stenting with a silicone keel for 3 weeks.







Table 2 Types of endoscopic treatment for 115 LTS
CO2-laser section/resection 84  73%
Nd-YAG/KTP laser 16  14%
Dilatation 37  32%
Temporary stenting 25  22%
Topical mitomycin-C 56  49%
(2 mg/ml for 2 min)
Treatments were often combined (for instance laser + dilatation +
mitomycin), hence a total number exceeding 115 (100%)
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Assessment of results
The improvement in airway patency was assessed at
each postoperative outpatient visit and with question-
naires when patients could not attend follow-up exami-
nation. The following items were recorded: no exertional
dyspnea, exertional dyspnea without airway restriction
at rest, dyspnea at rest and tracheotomy dependence.
At each control endoscopy, the size of the airway was
assessed with Savary-Gilliard tapered bougies (Wilson-
Cook Medical) and the Myer-Cotton classiﬁcation ap-
plied [34]. No thorough evaluation of the voice was
carried out.
Results
Fifteen (13%) patients with either grade I (6 cases) or
grade II (9 cases) were lost to follow-up. All patients
with grade III stenoses were available for the present
study. The median follow-up of the 100 patients left for
this study is 18 months with extremes of 6 months to
11 years.
The results on airway patency are shown in Table 3,
in comparison with the preoperative condition. In no
case did the endoscopic treatment aggravate the initial
condition. Either the patients were improved or they
recurred to a similar grade of stenosis. Preoperatively, 85
(74%) patients had a severe dyspnea at rest or were
tracheotomy dependent. After one or several endoscopic
treatment(s), there were only 19 (19 %) patients left in
the same category. Thirty-six patients lived fully nor-
mally with no exertional dyspnea, while 45 (45%) pa-
tients pursued normal daily activities with only
exertional dyspnea while practicing sports.
Six patients with a severe residual grade II stenosis
remained slightly dyspneic at rest and only 26 of the 39
(66%) tracheostomized patients could be decannulated.
The other 13 initial grade III stenoses recurred to a
similar degree of obstruction and required open surgery.
The analysis of the results according to the preoper-
ative grade of stenosis is shown in Table 4. All but one
grade I stenosis were improved to a nearly normal
(‡80% luminal size) airway. Conversely, the results were
much less favorable for grade III stenoses. Thirteen
(28%) recurred to a similar grade of obstruction and
prevented the patient from being decannulated. Nine-
teen (40%) improved to a grade II stenosis with signif-
icant residual exertional dyspnea or even slight dyspnea
at rest. Only 6 (13%) grade III stenoses were improved
to a nearly normal airway with no residual respiratory
symptoms, while 9 (19%) ended up with a grade I ste-
nosis. The intermediate group of 41 patients with a
grade II stenosis either improved to a nearly normal
airway 19/41 (46%) or to a grade I stenosis 20/41
(49%) (Fig. 1).
Looking at these results in a diﬀerent way, the rate of
improvement to a nearly normal airway declines from
92% (11/12 patients) for grade I to 46% (19/41 patients)
for grade II and 13% (6/47 patients) for grade III ste-
noses. In a similar fashion, grade II stenoses were im-
proved to grade I stenoses in almost half of the patients
(20/4149%), whereas only 9 of 47 (19%) grade III
stenoses were upgraded to the same level of improve-
ment.
The results of this series of 115 patients who under-
went an endoscopic treatment for the management of a
benign cicatricial LTS were compared to another series
of 104 patients treated for the same condition with open
surgery at our institution. Fifteen patients in the
endoscopy and four patients in the open surgery groups
were not available for the analysis of the postoperative
results. In the endoscopy group, there were 12 grade I,
41 grade II and 47 grade III stenoses and no grade IV
stenosis, whereas in the open surgery group, there were
no grade I, 3 grade II, 66 grade III and 31 grade IV
stenoses. The postoperative results on respiratory
symptoms are shown in Table 5. Although the grades of
stenosis were signiﬁcantly worse in the open surgery
group (97% grades III-IV stenosis) than in the endos-
copy group (0 grade IV, 47% grade III stenosis), the
ﬁnal outcome was much superior in the open surgery
group. Seventy-six percent versus only 36% of patients
were rehabilitated to a normal respiration without any
exertional dyspnea and only 5 versus 33% remained
tracheotomy dependent in the open surgery group when
compared to the endoscopy group.
Table 3 Comparison of preoperative and postoperative respiratory
symptoms. Insuﬃcient follow-up: n =1513%
Breathing Preoperative Postoperative
ÆTracheotomy 39 13
ÆDyspnea at rest 46 6
ÆExertional dyspnea 30 45
ÆNo exertional dyspnea 0 36
Total 115 100
Table 4 Comparison (grade by grade) of preoperative and postoperative degrees of stenosis (n =100)
Preoperative Postoperative results
Degree of stenosis £ 20% Grade I £ 50% Grade II £ 70% Grade III £ 99%
Grade I: 12 11 1 0 0
Grade II: 41 19 20 2 0
Grade III: 47 6 9 19 13
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Discussion
Back in 1982, Simpson et al. [46] set up predictive factors
of success or failure in the endoscopic management of
laryngeal and tracheal stenosis. Over the last 2 decades,
the advent of the microspot and super- or ultrapulse
technologies have somewhat broadened the indications
for the use of the CO2 laser in this ﬁeld [33]. More re-
cently, the topical application of mitomycin C as adju-
vant therapy to the endoscopic management of LTS has
decreased the risk of restenosis [30, 40], although con-
tradictory results have been published in the medical
literature [12, 19, 30, 40, 47]. These are mainly due to
signiﬁcant diﬀerences in the concentration doses of
mitomycin that were applied, and in the indications for
this adjuvant therapy.
This present study of 100 patients undergoing an
endoscopic treatment for a benign cicatricial LTS con-
ﬁrms that some grade II and even grade III stenoses can
be improved to a nearly normal (‡80% luminal size)
airway. The success rate however diminishes drastically
from preoperative grade I to grade III stenoses,
according to the Myer-Cotton classiﬁcation [34]. It must
be emphasized here that this classiﬁcation has been used
in a broader sense than originally proposed for pediatric
SGS, since it was applied to all adult and pediatric LTS
(supraglottic, glottic, subglottic and combined stenoses).
Except for congenital cartilaginous LTS, grade I
stenoses are amenable to endoscopic management with a
potentially high success rate (‡90% of cases with a
nearly normal airway). In the present series, almost half
(19/4146%) of grade II stenoses were improved to a
better than 80% luminal size, whereas in only 6 of 47
(13%) grade III stenoses could a similar result be
achieved, despite severe selection criteria, namely a
craniocaudal extension of less than 1.5 cm and the ab-
sence of loss of cartilage support. However, a thin cic-
atricial web-like and circumferential subglottic stenosis
was not considered an exclusion criterion in this series,
as in Simpson’s predictive factors of success or failure
[46].
When compared to open surgery for more severe
grades of stenosis, the results of the endoscopic treat-
ments are much less favorable (cf. Table 5). However,
the endoscopic approach is less invasive and less risky
and requires only a very short hospital stay for post-
operative surveillance in non-tracheostomized patients.
The key issue lies here in the proper selection of patients
and in the adherence to strict treatment criteria to avoid
any worsening of the initial condition (Fig. 2).
According to tissue interactions [33], the CO2 laser
(10,600 nm) in the ultrapulse mode is the preferred type
of laser for treating benign cicatricial stenoses. It should
be used either in suspension microlaryngoscopy for
laryngeal and subglottic stenoses, or with a rigid bron-
choscope and a CO2 laser coupler for tracheal and
bronchial stenoses. Nd-YAG (1,064 nm), diode
(980 nm) and KTP (532 nm) lasers, even in the contact
mode, induce much more heat diﬀusion into the sur-
rounding tissues and potentially higher rates of reste-
nosis. Anecdotal reports of success for benign subglottic
or tracheal stenoses [25] do not support the routine use
of these types of lasers for such indications.
Grade I to grade III stenoses presenting as web-like
diaphragms without loss of cartilage support represent
good indications for a ﬁrst try endoscopic laser treat-
ment, provided that the latter is not repeated in case of
Table 5 Comparison of postoperative results in 100 endoscopic
and 100 open surgery treatments for benign cicatricial LTS
Condition Endoscopic treatment Open surgery
n =100 n =100
No dyspnea 36 76
Exertional dyspnea 45 19
Dyspnea at rest 6 0
Tracheotomy 13 5
Fig. 1 Supraglottic stenosis combined with a glotto-subglottic
stenosis. a Posterior obstruction of the glottis by a tilted arytenoid
after partially successful laryngotracheal reconstruction. b Imme-
diate endoscopic view after partial right arytenoidectomy and laser
resection of a grade II subglottic stenosis (glotto-subglottic web). c
Endoscopic view 1 year after the endoscopic treatment. Persistence
of a small anterior subglottic web. No residual dyspnea, very good
voice
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recurrence to the initial grade of stenosis (Fig. 3). Healy
et al. have stressed the importance of a trial of endo-
scopic laser treatment in patients with acquired stenosis,
before an open procedure is attempted. Their experience
is based on the successful laser treatment of 177 pediatric
patients with LTS, granuloma and papilloma [20].
Reports in the literature following primary endo-
scopic treatment of LTS show success rates between 40
to 94%, depending on the appropriateness of the indi-
cation [2, 7, 9, 10, 14, 20, 25, 37, 44, 45]. In most cases of
acquired grade I stenosis, conservative endoscopic laser
therapy is eﬀective. The choice of treatment is more
crucial in grade II and mild grade III stenoses. The
extensive use of the CO2 laser in such cases can worsen
the initial condition. Vaporization of cartilaginous
structures is strictly contraindicated as it will expose
denuded cartilage into the lumen, weaken the laryngo-
tracheal framework and induce restenosis to a more
severe grade. This complication never occurred in our
series of 100 patients treated with the CO2 laser.
The excellent decannulation rates (‡90%) for grade
III and grade IV stenoses with partial cricotracheal
resection in children and adults oﬀer the proper alter-
native of treatment for severe grade III and IV stenoses,
with an acceptable morbidity [15, 16, 27, 39, 42]. For
mild grade III and grade II stenoses, laryngotracheal
reconstructions with costal cartilage graft are another
option in children [3, 4, 5, 18, 21, 32, 36].
Endoscopic CO2 laser resection of subglottic or upper
tracheal stenosis with dilatation and indwelling stents
should be proscribed. The necessity of prolonged stent-
ing merely reﬂects the weakness of the cartilaginous
framework of the larynx and trachea. Whenever possi-
ble, open surgery with resection or reconstruction of the
diseased segment should be envisaged [5, 13, 49].
Indwelling stents for a period of several months or years
Fig. 2 Indications for CO2-laser treatment of subglottic and
tracheal stenoses. Grades I and II subglottic or tracheal stenoses
deﬁnitely represent good indications for endoscopic CO2 laser
resection with or without additional dilatation. The expected result
is superior if the stenosis does not involve the posterior wall of the
airway, especially at the level of the membranous trachea. For
grade III stenosis, the risk of recurrence is much higher, despite a
limited cranio-caudal extension of less than 1.5 cm
Fig. 3 Algorithm for the endoscopic treatment of benign laryngo-
tracheal stenosis. After a primary endoscopic treatment (CO2 laser/
dilatation/stenting), a recurrence of the stenosis to its initial grade
precludes any further endoscopic treatment. Open surgery should
be considered instead. If a ﬁrst endoscopic treatment improves the
initial condition, a second or third session can further optimize the
ﬁnal result. Stents should be used with extreme caution as they may
worsen the initial craniocaudal extension of a stenosis, rendering
further open surgery much more diﬃcult
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are only justiﬁed when no further airway resection or
reconstruction is possible. However, self-expandable
metallic stents should not be used in children, because
the rate and severity of complications are too high [23].
In adult patients who are unﬁt for open surgery, a self-
expendable metallic stent or a Dumon silicone stent [8]
can be envisaged as the ultimate solution, but this should
remain an exception. The subglottic location of the
stenosis adds to the therapeutic challenge of stenting.
When sitting in the supraglottic or subglottic regions,
the proximal end of the stent may induce ulceration and
granulation tissue formation with subsequent supra-
glottic or glotto-subglottic restenosis. In the trachea, an
indwelling stent can also induce granulation tissue for-
mation at both extremities and change a short stenosis
into a long inoperable stenosis. Stents should thus be
used with extreme caution for the primary treatment of
benign airway stenoses, but they are often indispensable
after a LTR for a complex LTS. The precise anatomical
conﬁguration of the stent and its hardness are of the
utmost importance [29, 48].
The management of posterior glottic stenosis (PGS)
requires expertise in the selection of the appropriate
candidate for the right type of treatment. Interarytenoid
adhesion with a residual posterior opening is usually not
associated with a cricoarytenoid (CA) joint ﬁxation.
Division of the scar with the CO2 laser is thus the ﬁrst
appropriate choice of treatment with a potentially high
success rate. True PGSs without residual posterior
opening deserve a ﬁrst try endoscopic treatment with the
CO2 laser and adjuvant topical application of mitomy-
cin-C at a dose of 2 mg/ml for 2 min [30]. Five to 7 days
of postoperative intubation with a soft blue-line Portex
tube help achieve a satisfactory result. If CA joint
mobility is restored, the abductive force of both pos-
terior cricoarytenoid muscles will prevent recurrence of
the PGS at least to some degree. In tracheostomized
patients, 2 to 3 weeks of stenting with an Easy LT-Mold
[29] ensures reepithelization of the posterior commissure
in abduction, thus recreating an adequate airway for
breathing. In case of true ﬁxation of the CA joints, a
laser arytenoidectomy, a posterior cordotomy or a
posterior costal cartilage graft should be envisaged.
When PGS is combined with a subglottic stenosis, open
surgery is mandatory in most cases. In 1989, Langman
et al. [20] reported failures of endoscopic treatment
associated with arytenoid ﬁxation and Duncavage et al.
[9] of laser vaporization for combined glotto-subglottic
stenoses in 20 patients.
Conclusion
The appropriate management of LTS requires a high
degree of expertise in endoscopic and open surgery. The
numerous treatment modalities available for both ap-
proaches render the selection of the right patient for the
right type of treatment diﬃcult. Notwithstanding, a few
basic principles should always be respected in the
endoscopic management of LTS. Due to its tissue
interactions, the CO2 laser is the laser of choice for
mature cicatricial LTS. It should be used in the ultra-
pulse mode (150 mJ/cm2) with a microspot (250 mu at
400-mm focal distance). For dilatation, tapered bougies
(Savary-Gilliard or laryngeal dilators) should be gently
passed through mature stenoses after radial incisions
with the CO2 laser according to Shapshay’s technique
and a single adjuvant topical application of mitomycin-
C at a dose of 2 mg/ml for 2 min may help improve the
ﬁnal outcome. Stenting of the airway after an endo-
scopic treatment should be used with extreme caution in
order to avoid any worsening of the initial condition.
The adage ‘‘primum nihil nocere’’ should be of pri-
mary concern for the endoscopic treatment of LTS,
knowing that open surgery can always solve the prob-
lem, albeit with potentially more invasiveness and mor-
bidity. This report of 100 consecutive patients treated by
endoscopic means for grade I to III stenoses demon-
strates that a signiﬁcant number of grade I and II ste-
noses (and, to a lesser degree, grade III stenoses) can be
improved to a nearly normal airway by endoscopic
means only.
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